Carol Cronenberger Selected Research

Headache (Headaches)

9/2017

Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carol Cronenberger Research Topics

Disease

8	Rheumatoid Arthritis 09/2023 - 01/2018
2	Hypersensitivity (Allergy) 01/2018 - 12/2013
2	Alzheimer Disease (Alzheimer's Disease) 09/2017 - 12/2013
1	Type 2 Diabetes Mellitus (MODY) 01/2024
1	Migraine Disorders (Migraine) 01/2024
1	Obesity 01/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Myocardial Infarction 01/2018
1	Injection Site Reaction 01/2018
1	Opportunistic Infections (Opportunistic Infection) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Rheumatic Diseases (Rheumatism) 01/2018
1	Headache (Headaches) 09/2017

Drug/Important Bio-Agent (IBA)

8	Biosimilar PharmaceuticalsIBA 09/2023 - 01/2018
5	PF-06410293IBA 09/2023 - 01/2018
5	Adalimumab (Humira)FDA Link 09/2023 - 01/2018
2	Infliximab (Remicade)FDA Link 04/2020 - 01/2019
2	GP1111IBA 04/2020 - 01/2019
2	ponezumabIBA 09/2017 - 12/2013
2	Amyloid (Amyloid Fibrils)IBA 09/2017 - 12/2013
1	Cytochrome P-450 CYP2C9IBA 01/2024
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2024
1	Cytochrome P-450 CYP3AIBA 01/2024
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Rituximab (Mabthera)FDA Link 11/2018
1	C-Reactive ProteinIBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	AntibodiesIBA 12/2013
1	Immunoglobulin G (IgG)IBA 12/2013

Therapy/Procedure

2	Activities of Daily Living (ADL) 06/2022 - 01/2021
2	Therapeutics 01/2021 - 04/2020
1	Intravenous Infusions 12/2013